🏅 FDA Orphan Designation
Abelcet
Amphotericin B lipid complex
Manufacturer: Liposome Company, Inc.
Indicated for:
FDA-Approved Indications (1)
Transient predisposition to invasive pyogenic bacterial infectionOrphan Designation
Treatment of invasive fungal infections in patients who are refractory to or intolerant of conventional amphotericin B therapy.
Indications & Usage
Treatment of invasive fungal infections in patients who are refractory to or intolerant of conventional amphotericin B therapy.
💙 Support Programs
View all →Abelcet
Liposome Company, Inc.
Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.
Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.